According to the KEGG pathway analysis, the selected network may include the PI3K-Akt signalling route and the Prostate cancer signalling pathway, both of which lend credence to the idea that the polyherbal formulation could be useful in the treatment of prostate cancer. The gene discussed is AKT1; the disease is prostate carcinoma.